Montelukast Teva (Montelukast Sodium)

Montelukast selectively blocks the cysteinyl leukotriene receptor CysLT1, preventing leukotriene D4 and related compounds from binding. This blockade reduces bronchoconstriction, mucus production, and inflammatory cell recruitment, leading to improved airway patency and decreased allergic inflammation.

The appropriate dose of Montelukast Teva is determined by the prescribing healthcare professional based on the patient’s age, condition, and clinical response. Dosage recommendations are provided in the product labeling and should be followed exactly as directed by the prescriber.

Safety data for Montelukast in pregnancy are limited, and the product is classified in an unknown pregnancy category. It should only be used if the potential benefit justifies the potential risk to the fetus. While breastfeeding, the drug may pass into milk; a risk‑benefit assessment is required.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Montelukast belongs to the leukotriene receptor antagonist class, offering an oral alternative to inhaled corticosteroids or long‑acting beta‑agonists. It is particularly useful for patients with aspirin‑sensitive asthma or those who prefer a once‑daily tablet, but it may be less effective for severe asthma that requires high‑dose inhaled steroids.

Montelukast Teva tablets should be stored at ambient temperature, preferably below 25 °C. Keep them in the original container, protect from moisture and direct sunlight, and ensure they are out of reach of children.

Montelukast Teva is taken orally, usually once daily in the evening, with or without food. The tablet should be swallowed whole with a glass of water. Patients should follow the dosing schedule prescribed by their healthcare provider.

Serious adverse events, though rare, include neuropsychiatric effects such as depression, suicidal thoughts, or mood changes, as well as severe allergic reactions like anaphylaxis, Stevens‑Johnson syndrome, and liver injury. Any concerning symptoms should prompt immediate medical evaluation.

Montelukast Teva is contraindicated in patients with known hypersensitivity to montelukast or any of the tablet’s excipients. Caution is advised for individuals with a history of severe psychiatric disorders, liver disease, or those taking interacting medications that may alter its effectiveness.